MacuHealth PLUS+

$92.00

360 softgels | 90-day supply

With over a decade of scientific research, MacuHealthPLUS+ is recognized as the leading treatment protocol for those diagnosed with or at risk for Age-Related Macular Degeneration (AMD).

MacuHealth’s Triple Carotenoid Formula is clinically proven to effectively rebuild macular pigment. Based on the AREDS formula, MacuHealthPLUS+ offers two important distinctions: safer levels of Zinc and fortified with 10mg of Meso-Zeaxanthin, the third, critical carotenoid.

MacuHealth+ is currently on backorder with an expected ship date of June 14, 2022.

Available on backorder

Description

Vitamins for Macular Degeneration

Based on the AREDS2* study MacuHealth PLUS+ is specifically formulated by eye health experts for those patients already diagnosed with age-related macular degeneration. AREDS2* was published in 2013.  Here is what they found:

  1. AREDS2 demonstrated a statistically significant reduction of 9% in risk of disease progression to advanced AMD for patients receiving two of the three macular carotenoids (lutein and zeaxanthin) when compared with patients not receiving these antioxidants.
  2. The reduction in concentration of zinc from 80mg to 25mg (as found in MacuHealth PLUS+) did not have an adverse effect on the desirable and observed reduced risk of progression to advanced AMD.

MacuHealth PLUS+  =  AREDS2* formulation, with two important distinctions:

  1. Reduced Zinc from 80mg to 25mg, thereby compliant with RDA (recommended dietary allowance) and therefore precluding the possibility of any increased risk for disease progression in AMD patients with a particular genetic background. Of note, AREDS2* has shown that there was no significant difference between the AMD group who received 25mg of zinc compared to the AMD group who received 80mg of zinc (in terms of benefits), supporting further the decision to recommend a lower (25mg) zinc dose for patients with AMD.
  2. The addition of 10mg of Meso-Zeaxanthin (the third and centrally dominant macular carotenoid), thereby facilitating maximum augmentation of macular pigment and facilitating optimization of visual performance in eyes with AMD.
    The evidence base for supplementation in patients with AMD favors an AREDS2* formulation, but without dangerous levels of Zinc, and using a supplement that contains all three macular carotenoids in a MZ:L:Z (mg) ratio of 10:10:2. The only such commercially available supplement is MacuHealth PLUS+.

Product Description

  • Pharmaceutical grade dietary supplement
  • Formulated for those diagnosed with Age-Related Macular Degeneration
  • The only eye supplement that contains all three carotenoids (Meso-Zeaxanthin, Lutein and Zeaxanthin) as found in the macular pigment
  • Contains 25 mg of zinc for maximum antioxidant protection
  • Clinically Tested and Gluten Free

Uses

  • Supports and Maintains Eye Health
  • Augments Macular Pigment
  • Enhances Visual Performance
  • May reduce the risk of AMD development and/or progression

Available In

  • 360 softgels (90-day supply)

*AREDS2 is a registered trademark of the United States Department of Health and Human Services (HHS)

Ingredients

Active Ingredients

  • Lutein 10 mg
  • Meso-Zeaxanthin 10 mg
  • Zeaxanthin 2 mg
  • Vitamin C (Ascorbic Acid) 500 mg
  • Vitamin E (d-Alpha Tocopheryl Acetate) 268 mg
  • Zinc (Zinc Oxide) 25 mg
  • Copper (Cupric Oxide) 1.2 mg

Inactive Ingredients

  • Marigold Flower Extract
  • Sunflower Oil
  • Gelatin Capsule (Gelatin, Glycerin, Purified Water, Annatto)
  • Yellow Beeswax
  • Tween 80
  • Soy Lecithin
  • Ascorbyl Palmitate

Supplement Certified

Supplement Certified, performed by the Nutrition Research Centre Ireland, means that the product has undergone independent 3rd party analysis to confirm that the active ingredients are present in the supplement and match their quantity label claim. Only products that are Supplement Certified can claim stability and quality of ingredients for the consumer.

Directions

Take 4 Softgels daily, preferably with a meal.